Puma Biotechnology PBYI Stock
Puma Biotechnology Price Chart
Puma Biotechnology PBYI Financial and Trading Overview
| Puma Biotechnology stock price | 3.04 USD |
| Previous Close | 3.52 USD |
| Open | 3.46 USD |
| Bid | 0 USD x 1300 |
| Ask | 0 USD x 1000 |
| Day's Range | 3.46 - 3.58 USD |
| 52 Week Range | 2.08 - 5.16 USD |
| Volume | 218.85K USD |
| Avg. Volume | 264.92K USD |
| Market Cap | 165.81M USD |
| Beta (5Y Monthly) | 1.009507 |
| PE Ratio (TTM) | 32.272728 |
| EPS (TTM) | 0.62 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 4.75 USD |
PBYI Valuation Measures
| Enterprise Value | 206.83M USD |
| Trailing P/E | 32.272728 |
| Forward P/E | 17.75 |
| PEG Ratio (5 yr expected) | 0.04 |
| Price/Sales (ttm) | 0.7053637 |
| Price/Book (mrq) | 6.407942 |
| Enterprise Value/Revenue | 0.88 |
| Enterprise Value/EBITDA | 4.579 |
Trading Information
Puma Biotechnology Stock Price History
| Beta (5Y Monthly) | 1.009507 |
| 52-Week Change | 32.95% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 5.16 USD |
| 52 Week Low | 2.08 USD |
| 50-Day Moving Average | 3.05 USD |
| 200-Day Moving Average | 3.34 USD |
PBYI Share Statistics
| Avg. Volume (3 month) | 264.92K USD |
| Avg. Daily Volume (10-Days) | 229.9K USD |
| Shares Outstanding | 46.71M |
| Float | 32.52M |
| Short Ratio | 5.9 |
| % Held by Insiders | 17.38% |
| % Held by Institutions | 59.28% |
| Shares Short | 1.36M |
| Short % of Float | 3.43% |
| Short % of Shares Outstanding | 2.91% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 2.04% |
| Operating Margin (ttm) | 15.24% |
| Gross Margin | 75.55% |
| EBITDA Margin | 19.21% |
Management Effectiveness
| Return on Assets (ttm) | 11.28% |
| Return on Equity (ttm) | 29.13% |
Income Statement
| Revenue (ttm) | 235.07M USD |
| Revenue Per Share (ttm) | 5.14 USD |
| Quarterly Revenue Growth (yoy) | 15.40% |
| Gross Profit (ttm) | 172.94M USD |
| EBITDA | 45.17M USD |
| Net Income Avi to Common (ttm) | 4.81M USD |
| Diluted EPS (ttm) | 0.11 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 71.22M USD |
| Total Cash Per Share (mrq) | 1.53 USD |
| Total Debt (mrq) | 113.64M USD |
| Total Debt/Equity (mrq) | 439.65 USD |
| Current Ratio (mrq) | 2.319 |
| Book Value Per Share (mrq) | 0.554 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 13.71M USD |
| Levered Free Cash Flow (ttm) | -7971000 USD |
Profile of Puma Biotechnology
| Country | United States |
| State | CA |
| City | Los Angeles |
| Address | 10880 Wilshire Boulevard |
| ZIP | 90024 |
| Phone | 424 248 6500 |
| Website | https://www.pumabiotechnology.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 192 |
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 (neratinib, oral), for the patients with early stage HER2-overexpressed/amplified breast cancer; for the use of neratinib in combination with capecitabine for the treatment of adult patients with advanced or metastatic HER2-positive breast cancer; and for HER2 mutation-positive solid tumors. Its products also includes PB272 (neratinib, intravenous), and PB357. It has a license agreement with Pfizer, Inc.; and sub-license agreement with Specialised Therapeutics Asia Pte Ltd., CANbridge BIOMED Limited, Pint Pharma International SA, Knight Therapeutics, Inc., Pierre Fabre Medicament SAS, and Bixink Therapeutics Co., Ltd. The company was founded in 2010 and is headquartered in Los Angeles, California.
Q&A For Puma Biotechnology Stock
What is a current PBYI stock price?
Puma Biotechnology PBYI stock price today per share is 3.04 USD.
How to purchase Puma Biotechnology stock?
You can buy PBYI shares on the NasdaqGS exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Puma Biotechnology?
The stock symbol or ticker of Puma Biotechnology is PBYI.
Which industry does the Puma Biotechnology company belong to?
The Puma Biotechnology industry is Biotechnology.
How many shares does Puma Biotechnology have in circulation?
The max supply of Puma Biotechnology shares is 49.61M.
What is Puma Biotechnology Price to Earnings Ratio (PE Ratio)?
Puma Biotechnology PE Ratio is 4.89516160 now.
What was Puma Biotechnology earnings per share over the trailing 12 months (TTM)?
Puma Biotechnology EPS is 0.62 USD over the trailing 12 months.
Which sector does the Puma Biotechnology company belong to?
The Puma Biotechnology sector is Healthcare.
Puma Biotechnology PBYI included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 17461.32 USD — |
+0.55
|
12.35B USD — | 17256.2 USD — | 17500.41 USD — | — - | 12.35B USD — |
| Dow Jones U.S. Biotechnology In DJUSBT | 2557.84 USD — |
+0.46
|
107.01M USD — | 2514.18 USD — | 2574.64 USD — | — - | 107.01M USD — |
| Stlmt ID NASDAQ Biotechnology NBX | 4151.81 USD — |
-0.14
|
— — | 3927.42 USD — | 4157.43 USD — | — - | — — |
| NASDAQ Global Select Market Com NQGS | 8542.33 USD — |
+0.55
|
— — | 8441.28 USD — | 8561.16 USD — | — - | — — |
| NASDAQ Biotechnology NBI | 4195.18 USD — |
+0.25
|
— — | 4128.39 USD — | 4221.72 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 933.61 USD — |
+0.28
|
— — | 922.07 USD — | 938.83 USD — | — - | — — |
- {{ link.label }} {{link}}